11-17533367-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000527720.5(USH1C):​c.-102C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.539 in 1,379,248 control chromosomes in the GnomAD database, including 202,227 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 23430 hom., cov: 28)
Exomes 𝑓: 0.54 ( 178797 hom. )

Consequence

USH1C
ENST00000527720.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.38

Publications

8 publications found
Variant links:
Genes affected
USH1C (HGNC:12597): (USH1 protein network component harmonin) This gene encodes a scaffold protein that functions in the assembly of Usher protein complexes. The protein contains PDZ domains, a coiled-coil region with a bipartite nuclear localization signal and a PEST degradation sequence. Defects in this gene are the cause of Usher syndrome type 1C and non-syndromic sensorineural deafness autosomal recessive type 18. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
USH1C Gene-Disease associations (from GenCC):
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • autosomal recessive nonsyndromic hearing loss 18A
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 11-17533367-G-C is Benign according to our data. Variant chr11-17533367-G-C is described in ClinVar as Benign. ClinVar VariationId is 262734.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.625 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH1CNM_153676.4 linkc.37-45C>G intron_variant Intron 1 of 26 ENST00000005226.12 NP_710142.1
USH1CNM_005709.4 linkc.37-45C>G intron_variant Intron 1 of 20 ENST00000318024.9 NP_005700.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH1CENST00000005226.12 linkc.37-45C>G intron_variant Intron 1 of 26 5 NM_153676.4 ENSP00000005226.7
USH1CENST00000318024.9 linkc.37-45C>G intron_variant Intron 1 of 20 1 NM_005709.4 ENSP00000317018.4

Frequencies

GnomAD3 genomes
AF:
0.567
AC:
82868
AN:
146130
Hom.:
23409
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.632
Gnomad AMI
AF:
0.366
Gnomad AMR
AF:
0.530
Gnomad ASJ
AF:
0.558
Gnomad EAS
AF:
0.565
Gnomad SAS
AF:
0.586
Gnomad FIN
AF:
0.627
Gnomad MID
AF:
0.582
Gnomad NFE
AF:
0.532
Gnomad OTH
AF:
0.558
GnomAD2 exomes
AF:
0.540
AC:
123874
AN:
229536
AF XY:
0.541
show subpopulations
Gnomad AFR exome
AF:
0.603
Gnomad AMR exome
AF:
0.483
Gnomad ASJ exome
AF:
0.551
Gnomad EAS exome
AF:
0.556
Gnomad FIN exome
AF:
0.585
Gnomad NFE exome
AF:
0.525
Gnomad OTH exome
AF:
0.560
GnomAD4 exome
AF:
0.535
AC:
659945
AN:
1233008
Hom.:
178797
Cov.:
17
AF XY:
0.537
AC XY:
335195
AN XY:
624320
show subpopulations
African (AFR)
AF:
0.636
AC:
17659
AN:
27750
American (AMR)
AF:
0.495
AC:
21534
AN:
43474
Ashkenazi Jewish (ASJ)
AF:
0.557
AC:
13697
AN:
24598
East Asian (EAS)
AF:
0.573
AC:
21668
AN:
37812
South Asian (SAS)
AF:
0.589
AC:
48245
AN:
81880
European-Finnish (FIN)
AF:
0.601
AC:
27485
AN:
45700
Middle Eastern (MID)
AF:
0.578
AC:
2992
AN:
5174
European-Non Finnish (NFE)
AF:
0.523
AC:
477754
AN:
914152
Other (OTH)
AF:
0.551
AC:
28911
AN:
52468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
12643
25286
37928
50571
63214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12586
25172
37758
50344
62930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.567
AC:
82928
AN:
146240
Hom.:
23430
Cov.:
28
AF XY:
0.569
AC XY:
40382
AN XY:
71026
show subpopulations
African (AFR)
AF:
0.632
AC:
24361
AN:
38544
American (AMR)
AF:
0.530
AC:
7888
AN:
14888
Ashkenazi Jewish (ASJ)
AF:
0.558
AC:
1918
AN:
3440
East Asian (EAS)
AF:
0.566
AC:
2790
AN:
4932
South Asian (SAS)
AF:
0.587
AC:
2783
AN:
4738
European-Finnish (FIN)
AF:
0.627
AC:
5907
AN:
9418
Middle Eastern (MID)
AF:
0.577
AC:
164
AN:
284
European-Non Finnish (NFE)
AF:
0.532
AC:
35648
AN:
67056
Other (OTH)
AF:
0.558
AC:
1142
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
1595
3191
4786
6382
7977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.324
Hom.:
625
Bravo
AF:
0.581

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive nonsyndromic hearing loss 18A Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Usher syndrome type 1C Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.15
DANN
Benign
0.34
PhyloP100
-2.4
PromoterAI
-0.022
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2240489; hg19: chr11-17554914; COSMIC: COSV50014857; API